In the present study, we demonstrated that CAFs-derived FGF5 bound FGFR2 in NPC cells, thus decreasing DDP sensitivity by suppressing ferroptosis via the activation of Keap1/Nrf2/HO-1 signaling. The gene discussed is KEAP1; the disease is nasopharyngeal carcinoma.